Financial Highlight
Consolidated Statements of Income by Business Group
FY2010 (April 1, 2009 - March 31, 2010)
| (Millions of Yen) | Takara Holdings Inc.(Consolidated) | y-o-y(%) | Takara Shuzo Group | y-o-y(%) | Takara Bio Group | y-o-y(%) | Other, net | | Sales to customer | 190,525 | 98.8% | 166,969 | 98.6% | 19,325 | 102.2% | 4,229 | | Cost of sales | 115,805 | 97.4% | 104,046 | 97.1% | 9,286 | 103.5% | 2,472 | | Gross profit | 74,719 | 101.1% | 62,923 | 101.2% | 10,039 | 101.0% | 1,756 | | SG&A expenses | 66,146 | 101.6% | 55,794 | 102.0% | 9,485 | 99.7% | 866 | | Operating income | 8,572 | 96.9% | 7,129 | 95.5% | 553 | 129.7% | 889 | | Non-operating income | 923 | 85.3% | 479 | 91.9% | 327 | 109.5% | 117 | | Non-operating expenses | 769 | 62.4% | 301 | 69.2% | 15 | 4.2% | 451 | | Ordinary income | 8,727 | 100.3% | 7,306 | 96.8% | 864 | 245.9% | 555 | | Extraordinary gain | 137 | 17.8% | 10 | 4.9% | 113 | 490.7% | 12 | | Extraordinary loss | 655 | 51.3% | 268 | 96.4% | 281 | 102.2% | 106 | | Income before income taxes and minority interests | 8,208 | 100.2% | 7,049 | 94.0% | 697 | 699.7% | 461 | | Net income | 4,677 | 82.9% | 3,941 | 105.2% | 591 | 92.0% | 144 | | ―――― | ―――― | ―――― | ―――― | ―――― | ―――― | ―――― | ―――― | | Research and development expenses | 3,665 | 109.6% | 371 | 104.9% | 3,294 | 110.7% | -1 | | Capital expenditures | 3,645 | 100.8% | 2,436 | 102.2% | 1,069 | 100.9% | 138 | | Depreciation | 4,839 | 95.4% | 3,461 | 96.4% | 1,230 | 91.4% | 147 |
Consolidated Statements of Income
(Five-Year Summary)
| (Millions of Yen) | 2006/03 | 2007/03 | 2008/03 | 2009/03 | 2010/03 | | Sales to customer | 196,119 | 198,535 | 191,878 | 192,790 | 190,525 | | Cost of sales | 120,132 | 122,325 | 117,864 | 118,849 | 115,805 | | Gross profit | 75,986 | 76,210 | 74,014 | 73,941 | 74,719 | | SG&A expenses | 70,062 | 68,550 | 65,507 | 65,090 | 66,146 | | Operating income | 5,924 | 7,660 | 8,506 | 8,851 | 8,572 | | Non-operating income | 1,176 | 1,186 | 1,730 | 1,083 | 923 | | Interest and Dividends income | 342 | 453 | 719 | 771 | 486 | | Non-operating expenses | 1,169 | 1,000 | 1,113 | 1,233 | 769 | | Interest and discounts expenses | 523 | 524 | 559 | 606 | 577 | | Ordinary income | 5,931 | 7,846 | 9,123 | 8,701 | 8,727 | | Extraordinary gain | 5,231 | 1,622 | 1,590 | 769 | 137 | | Extraordinary loss | 3,287 | 1,807 | 2,391 | 1,277 | 655 | | Income before income taxes and minority interests | 7,876 | 7,660 | 8,321 | 8,193 | 8,208 | | Current income taxes | 3,446 | 3,731 | 3,798 | 4,075 | 3,589 | | Deferred income taxes | ▲ 634 | ▲ 408 | ▲ 405 | ▲ 1,774 | ▲ 272 | | Minority interests in net income | ▲ 256 | 129 | 270 | 252 | 214 | | Net income | 5,320 | 4,208 | 4,658 | 5,639 | 4,677 |
Main Consolidated Financial Indicators
| | 2006/03 | 2007/03 | 2008/03 | 2009/03 | 2010/03 | | Operating Income to sales ratio (%) | 3.0 | 3.9 | 4.4 | 4.6 | 4.5 | | Ordinary income to sales ratio (%) | 3.0 | 4.0 | 4.8 | 4.5 | 4.6 | | Return on total assets (ROA)(%) | 2.6 | 2.0 | 2.2 | 2.8 | 2.4 | | Return on equity (ROE)(%) | 5.6 | 4.1 | 4.6 | 5.8 | 4.9 | | Cash dividends / Shareholders’ equity ratio (%) | 1.9 | 1.6 | 1.8 | 1.9 | 1.9 | | Net income per share (EPS)(yen) | 24.38 | 19.44 | 21.53 | 26.32 | 22.20 | | Book value per share (BPS)(yen) | 470.09 | 470.09 | 462.00 | 437.42 | 459.92 |
| | 2006/03 | 2007/03 | 2008/03 | 2009/03 | 2010/03 | | Current ratio (%) | 238.1 | 215.9 | 253.7 | 276.9 | 233.7 | | Fixed assets / Shareholders’ equity ratio (%) | 102.0 | 98.3 | 87.1 | 79.6 | 77.3 | | Fixed assets / liability ratio (%) | 67.2 | 68.0 | 59.2 | 54.3 | 56.9 | | Shareholders’ equity (%) | 47.9 | 48.0 | 48.1 | 48.8 | 49.4 | | Interest coverage ratio (times) | 11.8 | 24.3 | 16.9 | 14.7 | 17.6 | | Asset turnover (times) | 0.97 | 0.93 | 0.91 | 0.97 | 0.99 | | Fixed assets turnover (times) | 2.08 | 1.94 | 2.04 | 2.39 | 2.56 | | Notes and accounts receivable turnover (days) | 94.4 | 94.6 | 93.5 | 88.3 | 88.2 | | Inventories turnover (days) | 45.5 | 46.5 | 48.1 | 46.2 | 46.0 |
Main Consolidated Financial Summary
| (Millions of Yen) | 2006/03 | 2007/03 | 2008/03 | 2009/03 | 2010/03 | | Total Current assets | 108,569 | 112,666 | 120,796 | 116,728 | 120,745 | | Fixed assets | 103,896 | 100,726 | 87,047 | 74,063 | 74,750 | | Total current liabilities | 45,605 | 52,176 | 47,607 | 42,158 | 51,663 | | Total long-term liabilities | 52,728 | 45,646 | 46,963 | 43,317 | 34,625 | | Total liabilities | 98,333 | 97,823 | 94,570 | 85,475 | 86,289 | | Common stock | 13,226 | 13,226 | 13,226 | 13,226 | 13,226 | | Shareholders’ equity | 101,839 | 102,507 | 99,969 | 93,093 | 96,666 | | Total assets | 212,466 | 213,393 | 207,843 | 190,792 | 195,495 |
| (Millions of Yen) | 2006/03 | 2007/03 | 2008/03 | 2009/03 | 2010/03 | | Cash dividends | 1,950 | 1,624 | 1,840 | 1,810 | 1,789 | | Capital expenditures | 5,633 | 3,617 | 3,852 | 3,616 | 3,645 | | Depreciation | 5,910 | 5,710 | 5,455 | 5,074 | 4,839 | | Research and development expenses | 3,574 | 3,593 | 3,643 | 3,343 | 3,665 | | Cash flows from operating activities | 6,211 | 12,782 | 9,816 | 8,954 | 10,452 | | Cash flows from investing activities | ▲ 12,687 | ▲ 7,526 | ▲ 411 | ▲ 7,769 | ▲ 7,350 | | Cash flows from financing activities | 344 | ▲ 1,558 | 3,414 | ▲ 9,294 | ▲ 3,219 | | Cash and cash equivalents at end of the year | 25,701 | 29,601 | 42,350 | 33,666 | 33,624 |
|
